Abstract. Background: One of the most important resistance mechanisms in bacteria is the increased expression of multidrug efflux pumps. To combat efflux related resistance, the development of new efflux pump inhibitors is essential. Materials and Methods: Ten phosphorus ylides were compared based on their MDR-reverting activity in multidrug efflux pump system consisting of the subunits acrA and acrB or acridine resistance proteins A and B and the multidrug efflux pump subunit TolC or outer membrane factor TolC (AcrAB-TolC) of Escherichia coli K-12 AG100 strain and its AcrAB-TolC-deleted strain. 
Multidrug resistance (MDR) is a serious problem for the treatment of various diseases, such as bacterial and fungal infections and cancer, due to the reduction or lack response of microorganisms as well as cancer cells to applied chemotherapeutic agents (1,2).
One of the major mechanisms of MDR is the overexpression of efflux pumps (EPs), which reduces the accumulation of toxic agents. In bacteria the resistance nodulation division (RND) transporters have a great impact on MDR phenotype. The major cause for the MDR phenotype is due to overexpresseion of efflux pumps that are part of the RND family of transporters, for example the AcrAB-TolC system (1).
These efflux pumps have the ability to recognize and extrude a large variety of unrelated antibiotics from the periplasmic space of the cell envelope, or from the cytoplasm. The energy required for the operation of the efflux pump is provided by the proton motive force created by the proton gradient resulting from electron transport (3).
The quorum-sensing system (QS) in bacteria is a regulatory system that controls gene expression depending on the density of the bacterial cell population. A transcriptional regulator (LuxR homolog), signal synthase (LuxI homologue) and autoinducer (acyl homoserine lactone) are crucial for the QS in most Gram-negative bacteria. SdiA, an E. coli LuxR homolog, has a great impact on the colonization of E. coli (4, 5) . SdiA is a homolog of QS regulators that detects N-acylhomoserine lactone (AHL) signals from other bacteria. SdiA represses the expression of virulence factors by interacting with unknown stationary-phase signals in E. coli O157:H7, and enhances multidrug resistance by activating MDR efflux pumps in E. coli (6) .
Organic compounds of phosphorus ylides (P-ylides) are a fascinating class of compounds (7) . The biological activity of P-ylides related to their ATP Binding Cassette Subfamily B Member 1 (ABCB1)-modulating activity in mouse lymphoma cells has already been described (8) , however, additional information is needed to describe their valuable biological activities in other aspects.
In this article, we report the MDR-modulating activities of P-ylides in bacteria related to the inhibition of efflux activity and QS.
Materials and Methods
Compounds. The synthesis of P-ylides was described previously (8) and the structures of the P-ylides (compounds 1-10) screened for their MDR-modulating activities are shown in Table I . The compounds were dissolved in dimethyl sulfoxide suspensions (OD of 0.6 at 600 nm) were transferred to 10 ml tubes in 3 ml aliquots and 50 µg/ml of compounds were added to the tubes which were the incubated at 37ºC. At intervals of 4 and 18 h of culture, the tubes were centrifuged at 12,000 × g for 2 min. Pellets were suspended in 100 µl TE buffer containing 1 mg/ml lysozyme by vigorous vortexing and were incubated at 37°C for 10 min. The total RNA was isolated in an RNase-free environment using NucleoSpin RNA kit (Macherey Nagel, Germany) according to the manufacturer's instructions. Purified RNA was stored in RNase-free water in nuclease-free collection tubes and was maintained at −20ºC until quantification was performed. The concentration of the extracted RNA templates was assessed by spectrophotometry at 260 nm. The forward and reverse primers used for assessment of the activity of the transporter genes acrA, acrB, the regulator marR and the QS regulator sdiA are shown in Table II .
Compounds 1-10 did not have any antibacterial effect on the AcrAB-TolC-expressing E. coli AG100 (MDR) strain nor its AcrAB-TolC-deleted progeny E. coli AG100A (EPdeleted strain) (MIC above 100 µg/ml), except for 6, which had a mild, non-significant effect on the EP-deleted strain (MIC=50 μg/ml).
The activity of the compounds was compared based on the relative final fluorescence index (RFI) of the real-time accumulation curves (Table III) .
In the case of real-time EB accumulation by Light Cycler thermocycler, the amount of EB accumulated by cells is higher if the difference between RF treated and RF untreated is greater, therefore, the degree of inhibition of the EP system by the compound becomes greater.
The majority of the P-ylides were found to inhibit the AcrAB-TolC system of E. coli except Ph 3 P=C(COCF 3 )COPh (3), Ph 3 P=C(COC 2 F 5 )COPh (7) and Ph 3 P=C(COC 3 F 7 )COPh (8), with had little or no effect on the intracellular EB accumulation in the E. coli AG100 and the AG100A strains. Among the P-ylide series, Ph 3 P=C(COCF 3 )OMe (2), Ph 3 P=C(COCF 3 )CHO (4) and Ph 3 P=C(COCF 3 )COMe (5) exhibited strong AcrAB-TolC pump-inhibiting properties compared to the AcrAB-TolC pump-deficient mutant strain. The most potent derivative was 4 and its effect was more pronounced on the MDR E. coli strain compared to the pump-deleted E. coli strain. This activity suggests that the compound may interfere with the proton motive force because AcrB utilizes proton motive force as energy for its transport function.
The P-ylides were not able to inhibit the QS in the applied systems compared to the positive control AO (data not shown).
Regarding the effect of P-ylides on the relative expression of efflux pump and QS genes in E. coli AG100, the most effective compounds 2, 4, and 5 were selected for gene-expression studies. In the assay, the gene of the multidrug efflux pump subunit AcrB, the gene of the periplasmic AcrA subunit, the component of the E. coli mar locus (multiple antibiotic resistance), and the gene of the LuxR homologue SdiA were investigated. As shown in Figure 1A , compound 2 at 50 µg/ml up-regulated all the genes studied after 4 h of exposure, however, after 18 h, the gene expression Compound 5 up-regulated the expression levels of acrA and acrB after 4 h, although after 18 h, the up-regulation of these genes was not significant (less than 2-fold increase) as presented by Figure 1C .
Discussion
Some phenothiazines and hydantoins are known to be EPIs against both bacteria and cancer cells (13) . However, P-ylides 3, 7 and 8 have been shown to have activity against the EPs of cancer cells (8) , but not to have activity against the EP of bacteria.
It is important to note that ABC transporters are primary efflux pumps deriving their energy from the hydrolysis of ATP, however, the AcrAB-TolC system is a threecomponent proton motive force-dependent multidrug efflux system. The most effective compounds in the present bacterial system were compounds 2, 4, and 5, which inhibi ted the AcrAB-TolC system and influenced the expression of the genes acrA and acrB, which are constituents of the AcrAB-TolC system. In addition, although the compounds are not QS inhibitors, compound 4 did increase the expression of sdiA after 18 h exposure.
It can be concluded that in the COCF 3 series (compounds 1-6) , the MDRreverting activity in the MDR E. coli strain was intensified in the following order: CHO (4) > OMe (2), COMe (5) >> CO 2 Et (6), COPh (3), CN (1).
Thus, some structurally related trifluoroacetylated P-ylides differ in their MDRreversal activities between cancer cells and bacterial strains, indicating that the compounds differently act as inhibitors of primary (ABCB1) and secondary (AcrB) efflux pumps because these pumps differ in their energy source for driving the pump (ATP and PMF, respectively).
The present study demonstrated that trifluoroacetylated P-ylides may be attractive lead EPIs for further development as a MDR-reversing agents, however, their mode of action should be elucidated by structure-activity relationship studies. Table II . Forward and reverse primers used for assessment of the activity of the transporter genes acrA and acrB, the regulator marR and the quorum-sensing regulator sdiA of Escherichia coli AG100. 
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